company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8421000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,83066000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,509000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1381000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,653000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,94030000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1550000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,41000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,41000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,,totalassets,Total Assets,=,debit,usd,95621000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2649000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,358000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1002000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4009000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,4009000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,328927000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-237332000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,17000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,91612000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,91612000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,91612000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,,2011-06-30,2011-08-05 16:04:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,95621000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,21667000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,62781000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,542000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1153000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,561000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,86704000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1565000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,41000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,41000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,,totalassets,Total Assets,=,debit,usd,88310000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2466000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,321000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1357000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,4144000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,4144000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,331054000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-246886000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,84166000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,84166000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,84166000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,,2011-09-30,2011-11-04 15:46:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,88310000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,24490000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,55206000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,370000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1508000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,250000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,81824000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1653000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,6906000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,41000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,6947000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,,totalassets,Total Assets,=,debit,usd,90424000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2445000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2171000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,996000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5612000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,10472000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,10472000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16084000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,334856000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-260513000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,74340000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,74340000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,74340000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,,2012-03-31,2012-05-07 17:16:08+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,90424000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,18476000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,41167000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,199000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3241000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,579000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,63662000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1532000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,21077000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,41000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,21118000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,,totalassets,Total Assets,=,debit,usd,86312000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2649000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2208000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1295000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6152000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,9931000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,9931000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16083000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,336477000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-266241000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-7000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,70229000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,70229000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,70229000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,,2012-06-30,2012-08-03 15:31:14+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,86312000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,13724000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,44178000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,311000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3504000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,674000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,62391000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1467000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,17914000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,41000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,17955000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,,totalassets,Total Assets,=,debit,usd,81813000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1745000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2446000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1831000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6022000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,9389000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,9389000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,15411000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,338418000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-272031000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,15000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,66402000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,66402000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,66402000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,,2012-09-30,2012-11-02 15:33:44+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,81813000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12177000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,45088000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,258000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3667000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,236000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,120000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,61546000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1464000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,12795000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,39000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12834000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,,totalassets,Total Assets,=,debit,usd,75844000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2533000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2286000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1134000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5953000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,8305000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,8305000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,14258000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,343955000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-282394000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,25000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,61586000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,61586000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,61586000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,,2013-03-31,2013-05-09 13:41:16+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,75844000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12052000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,35224000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,273000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4918000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,969000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,285000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,53721000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1587000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,18849000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,39000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,18888000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,,totalassets,Total Assets,=,debit,usd,74196000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3294000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2318000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1443000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7055000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,7763000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,7763000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,14818000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,347223000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-287844000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,59378000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,59378000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,59378000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,,2013-06-30,2013-08-02 16:50:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,74196000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,80309000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,39913000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,208000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4880000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,684000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,149000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,126143000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1494000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,12690000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,39000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,12729000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,,totalassets,Total Assets,=,debit,usd,140366000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2665000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2300000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2039000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7004000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,7221000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,7221000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,14225000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,420104000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-293989000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,26000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,126141000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,126141000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,126141000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,,2013-09-30,2013-11-04 16:50:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,140366000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,126823000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,320000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,86607000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,383000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5360000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,370000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,349000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,220212000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1410000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,30384000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1870000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,39000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,33878000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,,totalassets,Total Assets,=,debit,usd,255500000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6112000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,8548000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1471000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,275000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16406000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,19301000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,748000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1620000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,21669000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,38075000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,527109000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-309705000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,21000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,217425000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,217425000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,217425000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,,2014-03-31,2014-05-07 15:56:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,255500000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,99270000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,320000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,94386000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,311000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6969000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1053000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,671000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,202980000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1622000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,42741000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1870000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,39000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,46235000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,,totalassets,Total Assets,=,debit,usd,250837000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5709000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,8842000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1973000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,275000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16799000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,17283000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,748000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1650000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,19681000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,36480000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,531010000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-316686000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,33000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,214357000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,214357000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,214357000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,,2014-06-30,2014-07-29 16:25:13+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,250837000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,11205000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,320000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,151219000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,313000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,8474000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,751000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,887000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,173169000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1566000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,69049000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1870000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,108000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,72612000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,,totalassets,Total Assets,=,debit,usd,247347000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7999000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,8556000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2664000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,275000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,19494000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,15266000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,748000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1700000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17714000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,37208000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,534317000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-324231000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,53000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,210139000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,210139000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,210139000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,,2014-09-30,2014-10-28 16:32:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,247347000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,25256000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,320000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,170647000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,398000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6638000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,587000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,100000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,203946000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2995000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,29822000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,157000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,31564000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,,totalassets,Total Assets,=,debit,usd,238505000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6806000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,11184000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1703000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,275000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,19968000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,11049000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,11049000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,31017000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,541332000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-333869000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,25000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,207488000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,207488000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,207488000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,,2015-03-31,2015-04-28 16:32:08+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,238505000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,10768000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,203462000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,393000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5179000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1089000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,114000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,221005000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3217000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,3948000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,193000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5726000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,,totalassets,Total Assets,=,debit,usd,229948000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9512000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9524000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2020000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,21056000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,8948000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,8948000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,30004000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,545942000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-345995000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,199944000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,199944000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,199944000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,,2015-06-30,2015-08-06 16:37:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,229948000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,34287000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,185042000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,399000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7004000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,951000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,227683000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3063000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,185000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1770000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,,totalassets,Total Assets,=,debit,usd,232516000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8888000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,10461000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2779000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,22128000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6830000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6830000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,28958000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,558744000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-355240000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,54000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,203558000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,203558000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,203558000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,,2015-09-30,2015-10-30 16:51:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,232516000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,33009000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,154572000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,402000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2567000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,588000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,191138000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3176000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1003000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,146000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2734000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,,totalassets,Total Assets,=,debit,usd,197048000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3111000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5261000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1722000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10094000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,7334000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,213000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,7547000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,17641000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,565071000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-385747000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,83000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,179407000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,179407000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,179407000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,,2016-03-31,2016-05-05 16:29:39+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,197048000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12955000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,159321000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,299000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2305000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1270000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,176150000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3025000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,146000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1731000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,,totalassets,Total Assets,=,debit,usd,180906000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7014000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5244000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2202000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14460000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6176000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,247000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6423000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,20883000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,572254000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-412322000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,91000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,160023000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,160023000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,160023000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,,2016-06-30,2016-08-04 16:23:41+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,180906000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,27986000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,117595000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,310000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1482000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1472000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,148845000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4882000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,9507000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,159000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,11251000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,,totalassets,Total Assets,=,debit,usd,164978000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6317000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4714000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2837000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13868000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5018000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2256000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,7274000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,21142000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,575046000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-431287000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,77000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,143836000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,143836000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,143836000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,,2016-09-30,2016-10-27 16:36:28+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,164978000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,18486000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,110780000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,398000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2401000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1709000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,133774000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7267000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2995000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1189000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5769000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,,totalassets,Total Assets,=,debit,usd,146810000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7425000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3600000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2039000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13064000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4135000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3928000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,8063000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,21127000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,583318000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-457543000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-92000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,125683000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,125683000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,125683000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,,2017-03-31,2017-05-10 16:56:36+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,146810000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,69837000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,180074000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,256000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3495000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2015000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,255677000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8347000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,16343000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1041000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,18969000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,,totalassets,Total Assets,=,debit,usd,282993000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9206000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,29542000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2909000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,41657000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,43409000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3887000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,47296000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,88953000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,664217000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-470034000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-143000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,194040000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,194040000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,194040000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,,2017-06-30,2017-08-09 16:46:23+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,282993000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,29894000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,206810000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,483000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3433000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1720000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,242340000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8500000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,16325000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1041000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,18951000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,,totalassets,Total Assets,=,debit,usd,269791000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10112000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,28357000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4474000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,42943000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,36326000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3870000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,40196000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,83139000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,669171000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-482388000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-131000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,186652000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,186652000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,186652000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,,2017-09-30,2017-11-09 16:24:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,269791000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,30708000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,198818000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,373000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3575000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2802000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,236276000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,33601000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,4986000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4720000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,11291000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,,totalassets,Total Assets,=,debit,usd,281168000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10970000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,35209000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3211000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,49390000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,23964000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,25449000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,49413000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,98803000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,697299000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-514549000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-385000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,182365000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,182365000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,182365000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,,2018-03-31,2018-05-09 21:57:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,281168000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,59406000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,480040000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,562000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4977000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5064000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,550049000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,37223000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,34182000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4688000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,40455000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,,totalassets,Total Assets,=,debit,usd,627727000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,14388000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,57215000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4346000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,75949000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,137731000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,26180000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,163911000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,239860000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,919213000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-531189000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-157000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,387867000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,387867000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,387867000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,,2018-06-30,2018-08-08 16:37:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,627727000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,39298000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,419272000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,683000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5567000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3382000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,468202000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,50497000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,1585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,86320000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,87905000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,,totalassets,Total Assets,=,debit,usd,606604000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,16424000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,51094000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,6605000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,74123000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,123917000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,28658000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,152575000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,226698000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,924182000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-544032000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-244000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,379906000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,379906000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,379906000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,,2018-09-30,2018-11-08 17:09:17+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,606604000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,80968000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,270028000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,594000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7311000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3727000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,362628000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,18281000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,39283000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,53170000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,69367000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,161820000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,,totalassets,Total Assets,=,debit,usd,542729000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,30135000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,54824000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,6168000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,91127000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,100639000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,6572000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,15210000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,122421000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,213548000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,935135000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-603949000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2691000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,328495000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,328495000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,686000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,329181000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,,2019-03-31,2019-05-08 16:34:14+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,542729000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,169222000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,2000000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,271877000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,766000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,12095000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5848000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,461808000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,21019000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,8450000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,39795000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,53892000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,88517000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,190654000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,,totalassets,Total Assets,=,debit,usd,673481000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,22505000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,50826000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,8714000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,82045000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,94189000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,6661000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,44838000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,145688000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,227733000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1080132000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-634233000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-765000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,445134000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,445134000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,614000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,445748000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,,2019-06-30,2019-08-07 16:44:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,673481000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,114291000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,2000000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,240561000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,680000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,21953000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4691000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,384176000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,26516000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,52789000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,38270000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,51741000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,86730000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,229530000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,,totalassets,Total Assets,=,debit,usd,640222000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,21965000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,47561000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,11024000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,80550000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,87798000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,6395000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,46151000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,140344000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,220894000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1085530000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-661540000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-4901000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,419089000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,419089000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,239000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,419328000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,,2019-09-30,2019-11-06 16:33:44+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,640222000.0
